Stock PRDS PARDES BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Pardes Biosciences, Inc.

Equities

PRDS

US69945Q1058

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from S&P TMI Index
CI
Pardes Biosciences Announces Closing of Tender Offer
AQ
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from NASDAQ Composite Index
CI
MediPacific, Inc. completed the acquisition of Pardes Biosciences, Inc. from a group of shareholders.
CI
Pardes Biosciences Receives Tender Offer for MediPacific Merger Deal
MT
MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences
BU
MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares
BU
PARDES BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pardes Biosciences, Inc. - PRDS
BU
Pardes Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
PARDES BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pardes Biosciences, Inc. - PRDS
BU
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
BU
North American Morning Briefing : Earnings -2-
DJ
PRDS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Pardes Biosciences, Inc. Is Fair to Shareholders
BU
Shareholder Alert: Ademi LLP investigates whether Pardes Biosciences, Inc. has obtained a Fair Price in its transaction with MediPacific
PR
Pardes Biosciences Agrees to Be Acquired by MediPacific; Shares Rise
MT
Pardes Biosciences Enters into Agreement to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rights
AQ
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from Russell 2500 Value Index
CI
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from Russell Small Cap Comp Value Index
CI
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from Russell 2000 Index
CI
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from Russell 3000 Value Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRDS Stock
  4. News Pardes Biosciences, Inc.